DIMENSIONAL FUND ADVISORS LP

Position in PYXS — Pyxis Oncology, Inc.

CIK 354204 AUSTIN, TX

Position in PYXS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$108,885

+$71,055 QoQ

Shares Held

36,175

+39.6% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 76 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 51% Shared 24% None 25%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. PYXS ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$108,885	36,175	+39.6%	Shares	Sole	2026-08-11
2026-03-31	$37,830	25,912	-48.2%	Shares	Sole	2026-05-07
2025-12-31	$57,575	50,066	+37.1%	Shares	Sole	2026-02-12
2025-09-30	$81,065	36,516	0.0%	Shares	Sole	2025-11-12
2025-06-30	$40,166	36,516	0.0%	Shares	Sole	2025-08-12
2025-03-31	$35,785	36,516	-67.1%	Shares	Sole	2025-05-13
2024-12-31	$173,238	111,051	+35.5%	Shares	Sole	2025-02-13
2024-09-30	$300,741	81,946	+0.0%	Shares	Sole	2024-11-07
2024-06-30	$271,200	81,934	-19.5%	Shares	Sole	2024-08-09
2024-03-31	$433,709	101,810	0.0%	Shares	Sole	2024-05-10
2023-12-31	$183,257	101,810	-33.8%	Shares	Sole	2024-02-07
2023-09-30	$306,003	153,771	+779.2%	Shares	Sole	2023-11-09
2023-06-30	$44,773	17,490	+44.7%	Shares	Sole	2023-08-09
2023-03-31	$48,468	12,087	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.